- Voglibose - (https://clinicaltrials.gov/ct2/show/NCT01993927 )
- Voglibose: An Alpha Glucosidase Inhibitor - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919386/ )
- Efficacy of voglibose in type 2 diabetes - (Â https://pubmed.ncbi.nlm.nih.gov/24798092/ )
- Voglibose administration before the evening meal improves nocturnal hypoglycemia in insulin-dependent diabetic patients with intensive insulin therapy - (https://pubmed.ncbi.nlm.nih.gov/10778865/ )
Vogipax-MP (0.2mg/7.5mg/500mg) - Vidakem Lifesciences Pvt. Ltd.
Vogipax-MP (0.2mg/7.5mg/500mg) Tablet
Generic : Voglibose
When is Vogipax-MP (0.2mg/7.5mg/500mg) prescribed?
It is prescribed for -